Tremfya 100 MG/ML one-pressml
Ended Awarded
- Contract number
- SPE2DB26FY2B6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,062
Award facts
- Contract value 100% obligated
- $19,061.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of TREMFYA 100 mg/ml (guselkumab), a biologic immunosuppressant medication used to treat psoriasis and other autoimmune conditions. This firm fixed-price delivery order, valued at $19,061.81, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025, indicating expedited delivery typical of pharmaceutical supply chain operations supporting military healthcare needs.
This delivery order is a child contract issued under AmerisourceBergen's larger SPE2DX IDC valued at $999.99 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and related military healthcare systems. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies supporting military and veteran healthcare across multiple therapeutic domains. The award reflects the company's continued role as a primary supplier within the DLA's pharmaceutical procurement strategy, enabling efficient delivery of essential medical products to federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FY2B6?
SPE2DB26FY2B6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FY2B6 worth?
The government has obligated $19,062 on SPE2DB26FY2B6.
Is contract SPE2DB26FY2B6 an order under another contract?
Yes. SPE2DB26FY2B6 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY2B6 competed?
The extent of competition for SPE2DB26FY2B6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award